Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
11
×
startups
11
×
life sciences
national blog main
funding
clinical trials
medical device
national top stories
san diego blog main
seattle
aphelion capital
boston
boston blog main
boston top stories
bristol-myers squibb
deals
diabetes
fda
financing
gv
healthcare
innovation
investing
ipo
medical devices
new york blog main
san diego
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
tech
vc
venture capital
20/20 healthcare partners
23andme
480 biomedical
acute myeloid leukemia
adverum biotechnologies
al guillem
What
raised
11
×
million
new
developing
medical
based
raises
financing
startup
adds
biotech
ceo
company
develop
device
devices
diabetes
drugs
fund
gv
including
investment
medicine
reduce
seattle
series
therapeutics
vc
ventures
week
accelerating
advance
agent
alleviate
amsterdam
analyzes
announced
area
arrhythmia
associated
Language
unset
Current search:
raised
×
startups
×
biotech
×
@techcrunch.com
1 month ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
5 years ago
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Magnolia Medical Captures $20M to Reduce Blood Culture Contamination
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@xconomy.com
5 years ago
OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million
@techcrunch.com
6 years ago
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes